Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice. - Wikidata - awgldk - TriplyDB

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

http://www.wikidata.org/entity/Q33828868

about

Shared molecular and functional frameworks among five complex human disorders: a comparative study on interactomes linked to susceptibility genes Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): a paradigm worth exploring The impairment of insulin signaling in Alzheimer's disease Rodent models of neuroinflammation for Alzheimer's disease At the interface of sensory and motor dysfunctions and Alzheimer's disease.Food for thought: the role of appetitive peptides in age-related cognitive decline Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease The ε3 and ε4 alleles of human APOE differentially affect tau phosphorylation in hyperinsulinemic and pioglitazone treated mice Protection against the synaptic targeting and toxicity of Alzheimer's-associated Aβ oligomers by insulin mimetic chiro-inositols.Intracerebroventricular streptozotocin exacerbates Alzheimer-like changes of 3xTg-AD mice Unraveling Alzheimer's: Making Sense of the Relationship between Diabetes and Alzheimer's Disease1 Folic Acid Reduces Tau Phosphorylation by Regulating PP2A Methylation in Streptozotocin-Induced Diabetic Mice.Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice Altered expression of diabetes-related genes in Alzheimer's disease brains: the Hisayama study.Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?High glucose promotes Aβ production by inhibiting APP degradation.Consequences of Aberrant Insulin Regulation in the Brain: Can Treating Diabetes be Effective for Alzheimer's Disease.Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation.Synergistic exacerbation of mitochondrial and synaptic dysfunction and resultant learning and memory deficit in a mouse model of diabetic Alzheimer's disease.Thyroid hormone's role in regulating brain glucose metabolism and potentially modulating hippocampal cognitive processes Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice.Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus.Brain-Wide Insulin Resistance, Tau Phosphorylation Changes, and Hippocampal Neprilysin and Amyloid-β Alterations in a Monkey Model of Type 1 Diabetes.A Role for Insulin in Diabetic Neuropathy.Genetic ablation of tau mitigates cognitive impairment induced by type 1 diabetes.Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology Pioglitazone ameliorates memory deficits in streptozotocin-induced diabetic mice by reducing brain β-amyloid through PPARγ activation How does diabetes accelerate Alzheimer disease pathology?Aβ oligomer-induced synapse degeneration in Alzheimer's disease.Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.The Janus face of PAMAM dendrimers used to potentially cure nonenzymatic modifications of biomacromolecules in metabolic disorders-a critical review of the pros and cons.Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.Insulin dysfunction and Tau pathology.Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases.Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Glucose regulates amyloid β production via AMPK.Molecular interaction between type 2 diabetes and Alzheimer's disease through cross-seeding of protein misfolding.Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease.Increased tau phosphorylation and impaired brain insulin/IGF signaling in mice fed a high fat/high cholesterol diet.

P2860

Q21135491-8B52833B-6969-41EB-BDCD-0D0443DB5385 Q26750648-34CC4752-FD33-431E-ACA0-2A4AB646C80A Q26861082-AA262F55-32CD-43E9-B3FD-90131FF880E5 Q26863763-BA6A158A-2981-4FD9-AF66-2F6A3EF047F9 Q26864804-DB494BFC-12B9-47A5-B9C0-EAC3C59BA13B Q27000410-9470B9DC-DA0C-4FE7-A13E-A3117055E898 Q27009988-5BE4E944-DB6E-4F54-916F-63BE6C9008DE Q28731520-3E6761AA-1049-4719-A330-817708FB2E99 Q28742884-9138E4CB-89D8-49C7-BD89-4A1427EB3C18 Q30415477-63DC1224-C8F3-483E-906E-7698140CF73E Q30573779-3856C457-679B-4967-B98E-EBD30B38400F Q33362745-C5670865-F10B-4B79-B140-2EF1047F2A42 Q33624894-ED046158-B454-4893-91DC-9CAD8B5B5B8E Q33677202-2411AE55-31BC-4B13-973F-D28BD4A1FEBC Q34027810-B5FC2C87-BA05-4CEC-A26D-FF07A5EAAB94 Q34608998-C2EBBCFB-7006-4BB8-85AA-6894ED8056CB Q34874591-103A5096-E3CA-421F-9377-3CC0746BB217 Q35687048-3CF11F01-7CC3-498F-970C-8E00BBD22590 Q35688334-25D32CDB-CFE6-47B3-8177-1BC319432092 Q35738734-509240BC-172C-46E1-A1FC-FBB566147323 Q35947049-D58B93A1-1D61-4BAE-A425-33F14A3A1A52 Q36605311-96D2723A-6F16-4128-A6E1-8901F3CC838D Q36772914-14D4BD6A-3C2E-43C3-8751-67BBD5C734E8 Q36792589-D1DA4C75-53BC-42DC-98E0-DA827ED34E83 Q37528638-4C40D59B-DF36-44B6-B951-E7EDC69EA638 Q37606025-77F12F80-4F38-40C7-8DCD-2CE0B33CAC1F Q37680075-2F1E0701-D416-4F12-8502-413441A812F6 Q37728905-42DDD45F-E4D4-4D5D-895E-5F57218D41F8 Q37788954-721F8D5C-5604-4A64-861E-8D4027DC3594 Q37871455-898AC6A3-2691-4016-80A7-DD005A6A372A Q38126701-E03DE34B-1E41-43A8-BD36-021A891BF2CD Q38161415-8508E0E3-3221-4E0E-A716-BC1037188D3A Q38177257-C6C588BB-47F2-4CD0-BA6B-CBA74E46150C Q38191590-046C645B-0A93-4BF1-904C-23DE7096A06C Q38268535-D42FFCCA-A064-4C8A-B6B4-723D4C869055 Q38828830-DFFCA367-56C8-4329-A5F6-845759EED972 Q38864538-05892F1C-F272-4FB5-8FEA-F7B5B152E548 Q39043775-1230ABB2-C7F8-491C-82CE-F42209D96F95 Q40746525-1A84D388-613D-44B8-BED7-A761DC747461 Q41170006-732DFBEA-AD62-4CA8-9F06-793B27031E1C

P2860

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

http://www.wikidata.org/entity/Q33828868

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

@ast

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

@en

type

label

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

@ast

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

@en

prefLabel

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

@ast

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

@en

P1433

Q33828868-1B495A61-0452-421B-AAEB-E2F47831FFE3

P1476

Q33828868-A8694B80-70C0-4415-A8FE-0CB2AE929377

P2093

Q33828868-1E26882A-B04D-4CEB-9592-1A7B89D4F41E

Q33828868-655EC68B-06DA-4A55-AB2F-051B5DFC3562

Q33828868-98D237FF-F235-4022-8AD2-D6A884740299

Q33828868-D493F994-746F-4B00-9C0C-E21F884F417B

P2860

Q33828868-023BEBA9-BD2B-42C3-8433-4BC314DE72FB

Q33828868-0313A2B0-27AA-4EB1-9DEC-D50DAAA536E5

Q33828868-046206E0-53DC-4321-BA50-143D16B6E697

Q33828868-098E18BC-6819-4B13-B6B8-A56CA7E421A3

Q33828868-0D422346-C51F-4581-8CD9-84153A97CFFC

Q33828868-1838DC76-6746-4538-9BF6-513CA60ED458

Q33828868-1BA1A31B-911C-465E-AF47-80CB4954EBB7

Q33828868-1D3D4DA8-1895-45D3-957B-2B99026A69CA

Q33828868-1F79BB72-CC13-4346-A092-286F79577270

Q33828868-21388DA4-3BD8-4A5C-B13A-26F8B040AF45

P304

Q33828868-5023D036-17A4-41D7-A4F2-546F1C27C665

P31

Q33828868-4DF01057-6349-4B63-BACC-90A15F6271B1

P356

Q33828868-878F7490-4C97-45DA-B110-8DB77F2123E5

P407

Q33828868-99D2C954-651E-47F9-A936-63A32D0425B3

P433

Q33828868-AC5E11C0-9854-4CE4-8057-6B3C9E2BE405

P478

Q33828868-95E7A6D2-9076-4790-B149-0818C92D2F44

P50

Q33828868-0CF5D88B-651C-46A8-82D3-FA10422DFAD0

Q33828868-2010F99D-98AB-42DD-BFD5-DA7AB9CA4FA9

P577

Q33828868-12FF7BE6-0854-4623-8AB1-ED686E693860

P5875

Q33828868-F6EB2975-B79B-4F37-9B0F-4D50B22DEC5F

P698

Q33828868-AA7D6C6F-4A73-4F05-BD78-F64D75F68E1E

P921

Q33828868-3124792B-022B-47BE-90BC-84774053FE35

Q33828868-6D658E75-337D-4B07-9146-649D9500061F

P932

Q33828868-B96084A3-C1A8-44CE-8120-EA21E1C9C9B4

P356

J.EXPNEUROL.2009.11.005

P1433

Experimental Neurology

P1476

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

@en

P2093

Corinne A Lee

http://www.w3.org/2001/XMLSchema#string

Corinne G Jolivalt

http://www.w3.org/2001/XMLSchema#string

Rosemarie Hurford

http://www.w3.org/2001/XMLSchema#string

Wilmar Dumaop

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropathological stageing of Alzheimer-related changes

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

The glamour and gloom of glycogen synthase kinase-3

Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

Alzheimer's disease and the aging brain.

Neurofibrillary and neurodegenerative pathology in APP-transgenic mice injected with AAV2-mutant TAU: neuroprotective effects of Cerebrolysin.

Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study.

P304

422-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPNEUROL.2009.11.005

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

223

http://www.w3.org/2001/XMLSchema#string

P50

Eliezer Masliah

Edward Rockenstein

P577

2009-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40024680

http://www.w3.org/2001/XMLSchema#string

P698

19931251

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

type-1 diabetes

P932

2864332

http://www.w3.org/2001/XMLSchema#string